Michael Stephens, M.D., a pediatric gastroenterologist at Mayo Clinic, discusses a recent study published in Gastroenterology about the effectiveness of drug therapy in pediatric patients with Crohn’s disease. The results showed that patients who received an anti-TNF therapy had improved outcomes at one year.
School Safety Partners is dedicated to creating long-term funding partnerships to support school safety best practices. We are both a community of interest and a facilitator of joint research projects, reaching out to the general public as well as stakeholders in the public, private, non-profit, and academic sectors. Our purpose is to create a space for stakeholders where true partnering can occur in order to make school safety sustainable beyond Federal funding. Since our start in January, 2008, our projects have addressed the legislative, training, compliance, funding, and public awareness sides of school safety.